Albaad Massuot Yitzhak Ltd. (IL:ALBA)
TASE:ALBA
Want to see IL:ALBA full AI Analyst Report?
Top Page
Albaad
(TASE:ALBA)
Select Model
Select Model
Rating:66Neutral
Price Target:
3,714.00
▲(2.20% Upside)
Action:Reiterated
Date:05/22/26
The score is driven primarily by improved financial performance (clear earnings and growth recovery) but tempered by meaningful leverage and inconsistent cash conversion. Valuation is supportive due to a low P/E, while technicals are only moderately positive with negative MACD despite prices holding above key moving averages.
Positive Factors
Revenue Recovery & Growth
Albaad's ~20% TTM revenue growth to ~1.77B reflects a durable recovery from prior loss-making years, indicating stronger demand and improved commercial execution. Sustained top-line expansion supports higher capacity utilization and long-term fixed-cost absorption, reinforcing competitive scale.
Negative Factors
High Leverage
Debt-to-equity around 1.5 leaves limited financial flexibility and increases sensitivity to weaker demand or higher interest costs. Elevated leverage constrains the firm's ability to fund capex, pursue M&A, or absorb cyclical downturns without deleveraging or refinancing, which is a medium-term constraint.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Recovery & Growth
Albaad's ~20% TTM revenue growth to ~1.77B reflects a durable recovery from prior loss-making years, indicating stronger demand and improved commercial execution. Sustained top-line expansion supports higher capacity utilization and long-term fixed-cost absorption, reinforcing competitive scale.
Read all positive factors
Albaad (ALBA) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪641.29M
Dividend Yield3.09%
Average Volume (3M)16.36K
Price to Earnings (P/E)7.5
Beta (1Y)0.77
Revenue Growth2.30%
EPS Growth86.44%
CountryIL
Employees1,670
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)4.16
Shares Outstanding18,647,507
10 Day Avg. Volume13,562
30 Day Avg. Volume16,359
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)1.42
Price to Sales (P/S)0.38
P/FCF Ratio11.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Albaad Business Overview & Revenue Model
Company Description
Albaad Massuot Yitzhak Ltd produces and sells wipes worldwide. It offers cleaning hand wipes including disinfecting and antibacterial wipes; cosmetic wipes, such as facial care, body, and feet care wipes; feminine hygienic product, which include t...
How the Company Makes Money
Albaad makes money mainly by manufacturing and selling absorbent hygiene products—primarily baby diapers—on a private-label/contract-manufacturing basis for retailers and brand owners. In this model, customers (e.g., large retail chains or consume...
Albaad Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
58
Neutral
Cash Flow
62
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.77B | 1.76B | 1.72B | 1.71B | 1.45B | 1.49B |
| Gross Profit | 371.42M | 349.10M | 347.93M | 344.37M | 235.00M | 270.70M |
| EBITDA | 222.58M | 214.77M | 192.42M | 176.03M | 78.18M | 192.56M |
| Net Income | 77.63M | 69.69M | 44.88M | 30.23M | -35.12M | -20.34M |
Balance Sheet | ||||||
| Total Assets | 1.49B | 1.50B | 1.51B | 1.58B | 1.60B | 1.57B |
| Cash, Cash Equivalents and Short-Term Investments | 10.06M | 10.81M | 25.16M | 19.13M | 27.19M | 18.24M |
| Total Debt | 651.03M | 702.17M | 712.92M | 829.03M | 836.53M | 802.11M |
| Total Liabilities | 993.80M | 1.02B | 1.07B | 1.18B | 1.24B | 1.14B |
| Stockholders Equity | 482.87M | 474.19M | 426.68M | 394.08M | 346.83M | 430.25M |
Cash Flow | ||||||
| Free Cash Flow | 78.65M | 56.34M | 101.60M | 120.98M | -67.58M | -38.08M |
| Operating Cash Flow | 157.44M | 127.49M | 152.50M | 233.23M | 18.57M | 52.58M |
| Investing Cash Flow | -77.58M | -101.94M | -9.51M | -110.94M | -30.36M | -170.24M |
| Financing Cash Flow | -81.86M | -40.28M | -135.56M | -134.49M | 20.46M | 103.68M |
Albaad Technical Analysis
Positive
3634.00
Price Trends
3282.50
Positive
3357.06
Positive
2959.79
Positive
Market Momentum
-17.48
Positive
54.69
Neutral
72.76
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:ALBA, the sentiment is Positive. The current price of 3634 is above the 20-day moving average (MA) of 3384.45, above the 50-day MA of 3282.50, and above the 200-day MA of 2959.79, indicating a bullish trend. The MACD of -17.48 indicates Positive momentum. The RSI at 54.69 is Neutral, neither overbought nor oversold. The STOCH value of 72.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:ALBA.
Albaad Peers Comparison
UnderperformOutperform
Sector (62)
IL:ALBA
Albaad
3,439.00
1,563.78
83.39%
IL:SANO1
Sano
37,880.00
4,756.27
14.36%
IL:AMRK
Amir Mark.
3,754.00
500.55
15.39%
IL:AVIV
Aviv
2,134.00
199.00
10.28%
IL:OVRS
Overseas
558.50
134.20
31.63%
IL:LSCO
Lesico
442.10
102.47
30.17%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.